DNA methylation profiling could be used to predict patients’ response to treatment for myelodysplastic syndrome, Spanish researchers have reported.
The researchers report finding an epigenetic “fingerprint” at diagnosis associated with a good clin...
8 months ago
NHS England has an open consultation on the Never Events Framework. The Serious Hazards of Transfusion (SHOT) haemovigilance scheme has flagged this consultation to the BSH. The SHOT team have a particular interest in Never Event 12: “Transfusion...
8 months ago
